Skip to content

Canopy News

Featured

Press Release
Clinical

Canopy Studies Selected for Oral and Poster Presentations at 2026 ASCO Annual Meeting

New data demonstrate the potential of the Canopy Remote Therapeutic Monitoring (RTM) Platform to improve patient care by reducing hospitalizations and increasing time on treatment. Canopy, the leader in Enterprise AI for oncology, today announced two abstracts selected for presentation at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. The studies demonstrate the potential of the Canopy RTM Platform to improve outcomes during systemic outpatient care.

Read more

Media Coverage